•
Sep 30, 2022

ARS Pharmaceuticals Q3 2022 Earnings Report

Total Revenue
$189K
Previous year: $528K
-64.2%
EPS
-$0.21
Previous year: -$1.89
-88.9%
Gross Profit
-$128K
Cash and Equivalents
$203M
Previous year: $301M
-32.4%
Free Cash Flow
-$16.6M
Previous year: -$19.2M
-13.3%
Total Assets
$271M
Previous year: $353M
-23.1%

ARS Pharmaceuticals

ARS Pharmaceuticals